ELANCO ANIMAL HEALTH INC
ELANCO ANIMAL HEALTH INC
INDIANAPOLIS, IN
Loading...
Price History
Market Data
| Market Cap | 11.58B |
| P/E Ratio | - |
| P/B Ratio | 1.77 |
| EPS | -0.48 |
| Dividend Yield | - |
| D/E Ratio | 1.04 |
| Current Ratio | 2.17 |
| Currency | USD |
Key Financial Metrics
4.71B
Revenue
-232.00M
Net Income
-0.48
EPS (Diluted)
326.00M
Free Cash Flow
Profitability
Gross Margin
55.0%
Operating Margin
-
Net Profit Margin
-4.9%
EBITDA
-
Returns & Efficiency
Return on Assets (ROA)
-1.7%
Return on Equity (ROE)
-3.5%
Dividend Yield
-
EPS
-0.48
Financial Health
Total Assets
13.36B
Total Debt
3.76B
Debt to Equity
1.04x
Current Ratio
2.17
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | INDIANAPOLIS, IN |
| Fiscal Year | 2025 |
Peers
LILLY ELI & CO
LLY
894.82B
P/E: --
ELI LILLY & CO
LLY
894.82B
P/E: --
533.28B
P/E: --
ABBVIE INC.
ABBV
355.49B
P/E: --
BEIGENE, LTD.
BEIGF
306.50B
P/E: 632.4
BEONE MEDICINES LTD.
BEIGF
306.50B
P/E: 632.4
275.14B
P/E: --
MERCK & CO. INC.
MRK
275.14B
P/E: --
Quick Links
Financial Statistics
Valuation
Market Cap$11.58B
P/E Ratio (TTM)-
Price to Book1.77
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin55.0%
Operating Margin-
Net Margin-4.9%
ROE-3.5%
ROA-1.7%
Leverage & Liquidity
Debt to Equity1.04
Current Ratio2.17
Total Debt$3.76B
Total Assets$13.36B
Stockholders' Equity$6.55B
Income Statement (FY 2025)
Revenue$4.71B
Gross Profit$2.59B
Operating Income-
Net Income$-232.00M
EPS (Diluted)$-0.48
Cash Flow (FY 2025)
Free Cash Flow$326.00M
Cash & Equivalents$545.00M
Revenue Growth6.2%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 450 ELANCO CIRCLE INDIANAPOLIS, IN 46221 |
| Phone | 877-352-6261 |
| Incorporated | None, None |
| EIN | 825497352 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 497.17M |
| Stockholders' Equity | $6.55B |
| Cash & Equivalents | $545.00M |
Recent Filings
View All
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-05-06
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-05-06
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-05
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-21
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-21
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-21
Local
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-04-09
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-04-08
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-04-08
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-07
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-07
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-07
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | ELANCO ANIMAL HEALTH INC |
| Ticker | ELAN |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | INDIANAPOLIS, IN |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 11.58B |
| Revenue | 4.71B |
| Net Income | -232.00M |
| P/E Ratio | - |
| EPS | -0.48 |
| Net Margin | -4.9% |
| ROE | -3.5% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...